Medical News: FDA Increases Warnings for Numbing Agent - in Public Health & Policy, FDA General from MedPage Today
Links shared publicly online about this topic.
- 370total visits
Medical News: FDA Increases Warnings for Numbing Agent - in Public Health & Policy, FDA General from MedPage Today
View full resource at medpagetoday.com
Tags: Healthcare, Public Health, Healthy Living, FDA, News, Medical
Most Recently Shared on April 12, 2011 at 3:02 pm By:
Medical News: FDA Increases Warnings for Numbing Agent - in Public Health & Policy, FDA General from MedPage Today http://t.co/mwUjKx2
FDA changes safety information on statin drugs - Harvard Health Publications
health.harvard.edu — “A new ruling from the FDA offers good news and some warnings for people who take a cholesterol-lowering statin. The good news—no more periodic blood tests for liver function. The warnings—taking a statin may increase the odds of developing type 2 diabetes or suffering reversible memory loss or problems thinking. The FDA warned that one statin, lovastatin, shouldn't be taken with some antibiotics, anti-fungal agents, or medications used to treat AIDS.” View full resource at health.harvard.edu
Most Recently Shared on February 29, 2012 at 8:56 pm By:
FDA: cholesterol-lowering statins to come with new safety warnings. http://t.co/VzvLwCdJ
Medical News: FDA Increases Warnings for Numbing Agent - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA warned healthcare professionals and customers of a methemoglobinemia risk associated with the numbing agent benzocaine.” View full resource at medpagetoday.com
Most Recently Shared on April 12, 2011 at 9:58 am By:
Physician Assistants Health News Feed
FDA warns providers of a methemoglobinemia risk associated with numbing agent benzocaine: http://bit.ly/gJTlVk
Advertisement
